These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28618988)

  • 1. Synthesis, Docking and Anti-Inflammatory Activity of Triazole Amine Derivatives as Potential Phosphodiesterase-4 Inhibitors.
    Grewal AS; Lather V; Pandita D; Dalal R
    Antiinflamm Antiallergy Agents Med Chem; 2017; 16(1):58-67. PubMed ID: 28618988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Anti-inflammatory Activity and Docking Studies of Some Newer 1,3-Thiazolidine-2,4-dione Derivatives as Dual Inhibitors of PDE4 and PDE7.
    Sharma H; Lather V; Grewal AS; Pandita D
    Curr Comput Aided Drug Des; 2019; 15(3):225-234. PubMed ID: 30280674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 2,2,4-trimethyl-1,2-dihydroquinolinyl substituted 1,2,3-triazole derivatives: their evaluation as potential PDE 4B inhibitors possessing cytotoxic properties against cancer cells.
    Praveena KS; Durgadas S; Suresh Babu N; Akkenapally S; Ganesh Kumar C; Deora GS; Murthy NY; Mukkanti K; Pal S
    Bioorg Chem; 2014 Apr; 53():8-14. PubMed ID: 24463218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and bioactivity of pyrazole and triazole derivatives as potential PDE4 inhibitors.
    Li YS; Tian H; Zhao DS; Hu DK; Liu XY; Jin HW; Song GP; Cui ZN
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3632-5. PubMed ID: 27289320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of nimesulide based new class of triazole derivatives as potential PDE4B inhibitors against cancer cells.
    Mareddy J; Nallapati SB; Anireddy J; Devi YP; Mangamoori LN; Kapavarapu R; Pal S
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6721-7. PubMed ID: 24215890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PdCl
    Thirupataiah B; Mounika G; Reddy GS; Kumar JS; Hossain KA; Medishetti R; Samarpita S; Rasool M; Mudgal J; Mathew JE; Shenoy GG; Rao CM; Chatti K; Parsa KVL; Pal M
    Eur J Med Chem; 2021 Oct; 221():113514. PubMed ID: 33992926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
    Chłoń-Rzepa G; Ślusarczyk M; Jankowska A; Gawalska A; Bucki A; Kołaczkowski M; Świerczek A; Pociecha K; Wyska E; Zygmunt M; Kazek G; Sałat K; Pawłowski M
    Eur J Med Chem; 2018 Oct; 158():517-533. PubMed ID: 30245393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of 3,5-disubstituted-1,2,4-oxadiazoles as potent inhibitors of phosphodiesterase4b2.
    Kumar D; Patel G; Vijayakrishnan L; Dastidar SG; Ray A
    Chem Biol Drug Des; 2012 May; 79(5):810-8. PubMed ID: 22176507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triazole-Pyridine Dicarbonitrile Targets Phosphodiesterase 4 to Induce Cytotoxicity in Lung Carcinoma Cells.
    Keerthy HK; Mohan S; Basappa ; Bharathkumar H; Rangappa S; Svensson F; Bender A; Mohan CD; Rangappa KS; Bhatnagar R
    Chem Biodivers; 2019 Sep; 16(9):e1900234. PubMed ID: 31287204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of novel quinazoline-based anti-inflammatory agents acting as PDE4B inhibitors.
    Serya RA; Abbas AH; Ismail NS; Esmat A; Abou El Ella DA
    Chem Pharm Bull (Tokyo); 2015; 63(2):102-16. PubMed ID: 25748781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
    Song G; Zhao D; Hu D; Li Y; Jin H; Cui Z
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4610-4. PubMed ID: 26320621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,2,3-Triazole-nimesulide hybrid: Their design, synthesis and evaluation as potential anticancer agents.
    Mareddy J; Suresh N; Kumar CG; Kapavarapu R; Jayasree A; Pal S
    Bioorg Med Chem Lett; 2017 Feb; 27(3):518-523. PubMed ID: 28011214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting next-generation PDE4 inhibitors in search of potential management of rheumatoid arthritis and psoriasis.
    Bhuktar H; Thirupataiah B; Mounika G; Samarpita S; Rithvik A; Sasi Priya SVS; Naskar R; Medishetti R; Jagadish PC; Parsa KVL; Rasool M; Chakraborty S; Pal M
    Bioorg Chem; 2024 Oct; 151():107689. PubMed ID: 39111119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking Studies of Curcumin and Analogues with Various Phosphodiesterase 4 Subtypes.
    Yi YX; Gaurav A; Akowuah GA
    Curr Drug Discov Technol; 2020; 17(2):248-260. PubMed ID: 30332967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CuCl
    Thirupataiah B; Mounika G; Sujeevan Reddy G; Sandeep Kumar J; Kapavarapu R; Medishetti R; Mudgal J; Mathew JE; Shenoy GG; Mallikarjuna Rao C; Chatti K; V L Parsa K; Pal M
    Bioorg Chem; 2021 Oct; 115():105265. PubMed ID: 34426160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis.
    Chu Z; Xu Q; Zhu Q; Ma X; Mo J; Lin G; Zhao Y; Gu Y; Bian L; Shao L; Guo J; Ye W; Li J; He G; Xu Y
    Eur J Med Chem; 2021 Mar; 213():113171. PubMed ID: 33482600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of pyridazinone derivatives as potential anti-inflammatory agents.
    Barberot C; Moniot A; Allart-Simon I; Malleret L; Yegorova T; Laronze-Cochard M; Bentaher A; Médebielle M; Bouillon JP; Hénon E; Sapi J; Velard F; Gérard S
    Eur J Med Chem; 2018 Feb; 146():139-146. PubMed ID: 29407945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Anti-inflammatory Potential of Thiazolidinone Derivatives of Benzenesulfonamide via Synthesis, Molecular Docking and Biological Evaluation.
    Bari SB; Firake SD
    Antiinflamm Antiallergy Agents Med Chem; 2016; 15(1):44-53. PubMed ID: 27216235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: Design, synthesis, and structure-activity relationship study of catecholamides bearing aromatic rings.
    Zhou ZZ; Ge BC; Zhong QP; Huang C; Cheng YF; Yang XM; Wang HT; Xu JP
    Eur J Med Chem; 2016 Nov; 124():372-379. PubMed ID: 27597413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of 2,3-disubstituted pyridines as potent, orally active PDE4 inhibitors.
    Kato Y; Kawasaki M; Nigo T; Nakamura S; Fusano A; Teranishi Y; Ito MN; Sumiyoshi T
    Bioorg Med Chem; 2013 Sep; 21(18):5851-4. PubMed ID: 23910988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.